A range of factors can contribute to fatty liver disease, including excessive alcohol consumption, but a prime player is obesity. In fact, 64 million people in the US alone have so-called non-alcoholic-liver disease, according to the University of Rochester (UR). But its scientists have discovered a new potential treatment option, in the form of a drug that protected mice from one of the complications of the condition in early testing.
.. Continue Reading Experimental drug puts the brakes on obesity-related liver diseaseCategory: Health & Wellbeing
Tags: Related Articles:
- A better model for star aging
- Artificial organs that look and bleed like the real thing take surgical practice to the next level
- Retinal cells imaged in living eyes
- New prehistoric bird unearthed from a toasty Canadian Arctic of long ago
- Stretchable polymer reverts back to original shape when triggered by body heat
- Three-dimensional, continuously multidirectional cloaking device developed
from New Atlas http://ift.tt/2vzMueK
No comments:
Post a Comment